CRY2 and non-Hodgkin lymphoma: Disrupted CRY2 and PER2 are associated with non-Hodgkin’s lymphoma [18] and the initiation and/or progression of AML [35], respectively, and CpG islands of PER3 are highly methylated in all patients with chronic myelogenous leukemia [36].